CBLL1 is hypomethylated and correlates with cortical thickness in transgender men before gender affirming hormone treatment

Autor: Rosa Fernández, Leire Zubiaurre-Elorza, Andrea Santisteban, Natalia Ojeda, Sarah Collet, Meltem Kiyar, Guy T’Sjoen, Sven C. Mueller, Antonio Guillamon, Eduardo Pásaro

Publikováno v: Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)

Abstract Gender identity refers to the consciousness of being a man, a woman or other condition. Although it is generally congruent with the sex assigned at birth, for some people it is not. If the incongruity is distressing, it is defined as gender

Externí odkaz: https://doaj.org/article/e77bfaadbd8147649c28764fe79cb323

Gender minority stress in transgender people: a major role for social network

Autor: Sarah Collet, Meltem Kiyar, Klara Martens, Jolien Vangeneugden, Victoria G Simpson, Antonio Guillamon, Sven C Mueller, Guy T’Sjoen

Publikováno v: The Journal of Sexual Medicine. 20:905-917

Background Gender minority individuals, on average, experience higher rates of mental health problems. Mounting work suggests that gender minority stress (GMS) contributes to mental health outcomes in transgender/gender-nonconforming individuals. Aim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5f4956182b244d9abb9b375775f828e3
https://doi.org/10.1093/jsxmed/qdad043

Changes in serum testosterone and adrenal androgen levels in transgender women with and without gonadectomy

Autor: Sarah Collet, Noor C Gieles, Chantal M Wiepjes, Annemieke C Heijboer, Tim Reyns, Tom Fiers, Bruno Lapauw, Martin den Heijer, Guy T'Sjoen

Publikováno v: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Journal of clinical endocrinology and metabolism, 108(2), 331-338. The Endocrine Society
The Journal of clinical endocrinology and metabolism, 108(2), 331-338. The Endocrine Society
Collet, S, Gieles, N C, Wiepjes, C M, Heijboer, A C, Reyns, T, Fiers, T, Lapauw, B, den Heijer, M & t'Sjoen, G 2023, ' Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy ', The Journal of clinical endocrinology and metabolism, vol. 108, no. 2, pp. 331-338 . https://doi.org/10.1210/clinem/dgac576, https://doi.org/10.1210/clinem/dgac576

Background Initiating feminizing gender-affirming hormone therapy (GAHT) in transgender women causes a steep decline in serum testosterone. It is unknown if testosterone concentrations change further and whether adrenal androgen levels change during

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc6a16c5f87abf2d6cf360b3519ddf3
https://hdl.handle.net/1854/LU-01GT969WVBMRV6WK0Q1S8RS2TQ

The ENIGI (European Network for the Investigation of Gender Incongruence) Study: Overview of Acquired Endocrine Knowledge and Future Perspectives

Autor: Carlotta Cocchetti, Alessia Romani, Sarah Collet, Yona Greenman, Thomas Schreiner, Chantal Wiepjes, Martin den Heijer, Guy T’Sjoen, Alessandra Daphne Fisher

Publikováno v: Cocchetti, C, Romani, A, Collet, S, Greenman, Y, Schreiner, T, Wiepjes, C, den Heijer, M, t’sjoen, G & Fisher, A D 2022, ' The ENIGI (European Network for the Investigation of Gender Incongruence) Study : Overview of Acquired Endocrine Knowledge and Future Perspectives ', Clinical Chemistry, vol. 11, no. 7, 1784 . https://doi.org/10.3390/jcm11071784
JOURNAL OF CLINICAL MEDICINE

Literature on the efficacy and safety of gender-affirming hormonal treatment (GAHT) in transgender people is limited. For this reason, in 2010 the European Network for the Investigation of Gender Incongruence (ENIGI) study was born. The aim of this r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b234b45c81a6862fc1780e4f31cc296
https://pubmed.ncbi.nlm.nih.gov/35407392

Osteoporosis and Bone Health in Transgender Individuals

Autor: Charlotte Verroken, Sarah Collet, Bruno Lapauw, Guy T’Sjoen

Publikováno v: Calcified tissue international. 110(5)

This review discusses the changes in bone mass, structure, and metabolism that occur upon gender-affirming hormonal treatment (GAHT) in transgender adults and adolescents, as well as their clinical relevance. In general, available evidence shows that

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d07f433370854de4bb721371e821d1ea
https://pubmed.ncbi.nlm.nih.gov/35366693